Editorial Board

Dr. Brull is Professor Emeritus of Anesthesiology and Perioperative Medicine at the Mayo Clinic College of Medicine and Science, Rochester, MN, and Consultant in the Department of Anesthesiology at the Mayo Clinic in Florida. He completed his medical education at the West Virginia University School of Medicine, Morgantown, WV, and an anesthesiology residency at the Yale University School of Medicine, New Haven, CT, followed by fellowships in Obstetric Anesthesia and Thoracic/Major Vascular Anesthesia at Yale University.

Dr. Brull is a Senior Examiner for the American Board of Anesthesiology (ABA) and an elected member of the Association of University Anesthesiologists (AUA) and the Academy of Anesthesiology, founder and Chief Medical Officer of a medical device company that seeks to eliminate residual neuromuscular block and its postoperative complications, and a member of four scientific advisory boards of international companies.

Dr. Brull’s research interests include neuromuscular junction physiology, muscle relaxants and neuromuscular monitoring, physiology and pharmacology of spinal anesthesia, and patient safety, topics supported by over $2.4M in funding from both industry and federal (National Institutes of Health) sources.

Competing Interests: Dr. Brull has intellectual property assigned to Mayo Clinic (Rochester, MN); is a consultant for Merck & Co., Inc. (Kenilworth, NJ); is a principal, shareholder and Chief Medical Officer in Senzime AB (publ) (Uppsala, Sweden); and an unpaid member of the Scientific/Clinical Advisory Boards for The Doctors Company (Napa, CA); Coala Life Inc. (Irvine, CA); NMD Pharma (Aarhus, Denmark); and Takeda Pharmaceuticals (Cambridge, MA).

Dr. Brummett is Bert N. LaDu Professor of Anesthesiology and Senior Associate Chair of Research at the University of Michigan, Ann Arbor, MI. He has more than 250 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network (OPEN) at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry, and emergency medicine.

In addition, Dr. Brummet’s research interests include predictors of acute and chronic post-surgical pain and failure to derive benefit from interventions and surgeries primarily performed to treat pain. He is particularly interested in the impact of a fibromyalgia-like or centralized pain phenotype on analgesic outcomes. He is the Co-PI of multiple NIH grants studying these concepts and also receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations.

Competing Interests: Dr. Brummett is a consultant for Alosa Health, Benter Foundation, Heron Therapeutics, and Vertex Pharmaceuticals. He also provides expert testimony.

Dr. Cereda is an intensive care physician and Associate Anesthetist and Associate Professor of Anesthesia at Massachusetts General Hospital. He studied medicine at the University of Milan, Milan, Spain, where he also trained and worked as a faculty member in the Department of Anesthesiology and Critical Care. After a research fellowship at the NIH-NHLBI, he completed his Anesthesiology residency at the University of North Carolina at Chapel Hill, NC, and his Critical Care fellowship at the University of Pennsylvania, Philadelphia, PA.

His research is directed at the pathophysiology of ARDS, using imaging (CT, functional, and metabolic MRI) to understand the mechanisms underlying the topographical dissemination of lung injury and to aid the development of individualized strategies of disease control.

Competing Interests: Dr. Cereda declares no competing interests.

Dr. Chan received a B.S. in biochemistry, honors, and M.D. from McGill University, Montreal, Quebec, Canada. He then obtained postgraduate training in Anesthesiology at University of Toronto, Toronto, Ontario, Canada, and board certification, FRCPC, Anesthesia. Dr. Chan is acknowledged by his colleagues as an international leader in the fields of regional anesthesia and pain medicine.

Dr. Chan serves on the editorial boards of Anesthesiology and Regional Anesthesia Pain Medicine. He has published over 200 peer-reviewed articles, 14 book chapters, and over 80 scientific abstracts. Other significant hospital and university contributions he has made include serving as Director of Faculty Development (present, University of Toronto), Chair of Research Committee (1997-2001, University of Toronto), and Chair of the Academic Committee, Department of Anesthesia (2006- present, Toronto Western Hospital).

Competing Interests: Dr Chan receives an honorarium from B. Braun, SonoSite, Aspen Pharma and Smiths Medical.

Dr. Steven P. Cohen is Professor of Anesthesiology & Critical Care Medicine, Neurology, Physical Medicine & Rehabilitation and Psychiatry and Behavioral Sciences at the Johns Hopkins School of Medicine and Uniformed Services University of the Health Sciences. He is also Chief of Pain Medicine and Director of the Blaustein Pain Treatment Center at Johns Hopkins and Director of Pain Research at Walter Reed National Military Medical Center.

Dr. Cohen has been active in teaching and pain research, having published over 400 peer-reviewed articles and book chapters in the past 20 years. Among his major contributions are the development of an FDA-approved denervation technique for treating sacroiliac joint pain (radiofrequency ablation), helping set up the first pain clinic in a war zone, inventing the IV ketamine test, and performing the first studies evaluating the epidural administration of biological agents for pain. Dr. Cohen has conducted research on facet arthropathy and epidural steroid injections that has changed the way the conditions are viewed and treated. He has been the first author on the “Pain” chapter in the last 5 editions of Cecil Textbook of Medicine. Dr. Cohen also serves on the Board of Directors for the American Academy of Pain Medicine and the Executive Board for ASRA.

In addition to his academic work, Dr. Cohen is a retired Colonel in the U.S. Army, and was deployed 4 times in support of operations in Bosnia, Iraq and Afghanistan. His research was instrumental in the passage of the 2008 Military Pain Care Act, and he served as an inaugural member of the U.S. Army Medical Advisory Board.

Competing Interests: Dr. Cohen has paid research (to institution) from Scilex and Avanos. He is a consultant for Scilex, Avanos, SPR, Persica, and SWORD. He also has a contract where the DoD pays Hopkins for him to work and do research.

Dr. Melissa Coleman is a pediatric anesthesiologist and Assistant Professor in the Department of Anesthesiology and Perioperative Medicine at the Penn State College of Medicine in Hershey, Pennsylvania. She is a trustee of the Wood Library-Museum of Anesthesiology in Schaumburg, Illinois.

Dr. Coleman's research interests include the pediatric patient experience, the history of anesthesiology, and the integration of historical narrative in resident education.

Competing Interests: Dr. Coleman declares no competing interests. 

Dr. Dahan is the head of Research and Professor of Anesthesiology in the Department of Anesthesiology at Leiden University Medical Center. He graduated from de Free University in Amsterdam (M.D.) and Leiden University (Ph.D.).

Dr. Dahan founded and has headed the Anesthesia & Pain Research Unit since 1995, a non-profit academic institute that performs outcome research in anesthesia and pain management aimed at the improvement of care in anesthesia and pain treatment and the wide distribution of gained knowledge, in close cooperation with non-academic partners.

Competing Interests: In the last 5 years Dr. Dahan received educational grants, consultancy fees and/or speaker fees from the following sponsors: Medasense Biometrics Ltd. (Israel), MSD BV (Netherlands), Grünenthal GmbH (Germany), Medtronic (USA), Trevena (USA), AMO Pharma (UK), Enalare (USA) and Bedrocan (Netherlands).

Dr. Einav is an Associate Professor in Anesthesiology and Critical Care Medicine at the Hebrew University, Jerusalem, Israel, and holds a master's degree in Clinical Epidemiology from the Braun School of Public Health. She has authored more than 350 papers, including multiple treatment guidelines, and is the chief editor of Principles and Practice of Maternal Critical Care. Prof. Einav has chaired the Intensive Care scientific subcommittee of the European Society of Anesthesiology and Intensive Care, as well as the Systematic Review Group of the European Society of Intensive Care Medicine. She has served as editor for the journal Intensive Care Medicine and is currently a senior editor for the Cochrane Critical Care, Anaesthesia and Emergency Medicine group (CARG). She is also a member of the American Society of Anesthesiologists Data Use Committee.

Dr. Einav's clinical experience includes work in critical care ambulances, airborne critical care transport, the department of emergency medicine and the intensive care unit. Her fields of research include the study of critical incidents and cardiopulmonary resuscitation, quality of care (in particular, mechanical ventilation and maternal critical illness) and the management of trauma patients during multiple casualty events.

Competing Interests: Dr. Einav declares no competing interests

Douglas Eleveld is an Assistant Professor at the Department of Anesthesiology of the University Medical Center Groningen in the Netherlands. His work is primarily in the field of pharmacometrics, with a focus on developing and evaluating pharmacokinetic and pharmacodynamic models. He has a PhD in the Medical Sciences from the Rijksuniversiteit Groningen and a Masters degree in Electrical Engineering from McMaster University.

Competing Interests: Dr. Eleveld received travel from BD.

As a physician scientist trained in anesthesiology and critical care medicine, Dr. Eltzschig is a funded investigator studying the role of hypoxia-elicited adaptive responses in the context of acute organ injury. Many surgical patients experience acute organ injury in their perioperative course, which is associated with significant morbidity and mortality. At present, therapeutic approaches to prevent or treat acute organ injury—such as acute kidney or lung injury, intestinal inflammation, or myocardial ischemia are very limited.

Dr. Eltzschig’s laboratory is particularly interested in studying endogenous adaptive pathways that are under the control of hypoxia-inducible factors. They have applied these molecular concepts in a wide range of disease models that are important for the field of anesthesiology and critical care medicine, including myocardial ischemia, acute kidney injury, liver ischemia or acute lung injury and intestinal inflammation. Many of their studies point toward an adaptive role for hypoxia-elicited signaling pathways, for example, by attenuating hypoxia-associated inflammation or promoting ischemia tolerance. They are currently exploring translational approaches to take these findings from bench to bedside, and they anticipate that some of these findings will lead to novel approaches to prevent or treat acute organ injury in patients who require major surgery or suffer from critical illness.

Dr. Eltzschig’s research laboratory is committed to providing junior investigators with unique training and career opportunities. As such, he has trained many scientists and physician scientists from the field of anesthesiology, surgery, immunology, and critical care medicine. Several of his trainees went on to become funded investigators (e.g., via NIH K08 or R01 mechanisms) or took over academic leadership roles.

Competing Interests: Dr. Eltzschig is funded through NIH and the Department of Defense and a sponsored research contract through Akebia Therapeutics, Inc.

Dr. Emala is the Henrik H. Bendixen Professor of Anesthesiology and Vice Chair for Research in the Department of Anesthesiology at Columbia University, New York, NY.

Dr. Emala’s research interests have focused on cellular signaling mechanisms that control smooth muscle contraction/relaxation, with a particular interest in anesthetic effects on airway tone and novel therapeutic approaches to airway smooth muscle relaxation in asthma. His laboratory demonstrated the cellular mechanism by which a clinically used muscle relaxant induced fatal bronchospasm in patients. These findings established new metrics for the demonstration of airway safety for new muscle relaxants under development for clinical use. His laboratory was also the first to demonstrate the expression of GABAA channels on airway smooth muscle. These findings are beginning to unravel a previously unrecognized role of GABAA channels on many peripheral cell types that may account for diverse physiological effects of anesthetics. Dr. Emala’s laboratory has been funded by the National Institutes of Health for over 25 years. He has published over 150 peer-reviewed manuscripts and has mentored over 30 individuals as developing physician-scientists.

Funding: The National Institutes of General Medical Sciences (NIGMS), National Heart, Lung & Blood Institute (NHLBI) and the National Center for Complementary and Integrative Health (NCCIH) of the National Institutes of Health.

Competing Interests: Dr. Emala is a Board Member of the Foundation for Anesthesia Education and Research (FAER).

Originally from Belgium where he trained in Anesthesiology and Pediatric Anesthesia at the Free University of Brussels, Dr. Faraoni is currently a Senior Associate in Cardiac Anesthesia in the Department of Anesthesiology, Critical Care, and Pain Medicine at Boston Children’s Hospital. Dr. Faraoni is also Associate Professor of Anaesthesia at Harvard Medical School.

Dr. Faraoni's interests include bleeding management, thrombosis and hemostasis in adults and children undergoing cardiac surgery.

Competing Interests: Dr. Faraoni declares no competing interests

Dr. Fernandez-Bustamante is an Associate Professor of Anesthesiology at the University of Colorado School of Medicine, Aurora, CO. She obtained her M.D., anesthesiology and postoperative care, and Ph.D. degrees in Spain, followed by a research fellowship in lung injury and a cardiothoracic anesthesia fellowship at Johns Hopkins University, Baltimore, MD. She currently practices general, bariatric, airway, and liver transplant anesthesia.

Dr. Fernandez-Bustamante’s broad clinical perspective aligns with her research interests in mechanical ventilation, lung inflammation, pulmonary management of surgical patients, and perioperative outcomes. She has led or participated in multiple single-center and multi-center (national and international) prospective and retrospective studies.

Competing Interests: Dr. Fernandez-Bustamante’s research has been funded by the Spanish Ministry of Education, the Department of Anesthesiology at the University of Colorado School of Medicine, the Foundation for Anesthesia Education and Research (FAER), the Merck investigator-initiated sponsored program (MISP), the Institute for Healthcare Quality Safety and Efficiency (IHQSE), the U.S. Department of Defense, and the NIH/NHLBI.

Dr. Julia Gálvez Delgado is an openly transgender pediatric anesthesiologist at Boston Children's Hospital, specializing in pediatric perioperative clinical informatics. Her professional journey commenced at The Children's Hospital of Philadelphia, where she assumed leadership positions within the Biomedical Informatics Program and the Pennsylvania Pediatric Medical Device Consortium. Subsequently, Dr. Gálvez Delgado held the esteemed positions of Division Chief and Vice Chair of Pediatric Anesthesiology at the University of Nebraska Medical Center before joining Boston Children's.

Beyond a steadfast commitment to clinical excellence, Dr. Gálvez Delgado's professional focus extends to the advancement of health delivery equity and inclusion, particularly within the realm of gender-affirming care. Specialized interests include the optimization of pediatric perioperative informatics, and she is resolute in contributing to a healthcare landscape that seamlessly integrates technological advancement with social inclusivity.

Competing Interests: Dr. Gálvez Delgado declares no competing interests.

Dr. Glance obtained his M.D. at Cornell and his undergraduate degree at Dartmouth. He is a cardiac anesthesiologist who trained at New York-Presbyterian Hospital (Cornell) for residency and Memorial Sloan-Kettering for critical care medicine. Dr. Glance has extensive experience working with large clinical and administrative data sets, multivariate modeling, risk adjustment, simulations, and bootstrapping techniques. He is a tenured Professor of Anesthesiology and Perioperative Medicine at the University of Rochester School of Medicine, with secondary appointments at RAND Health and in the Department of Public Health Sciences. Dr. Glance was the Principal Investigator on two ARHQ-funded RO1 grants focusing on risk adjustment (R01 HS 13617) and the impact of non-public reporting (R01 HS016737). He is currently a co-investigator on an NIMHD funded R01 grant (R01 MD012422), examining the impact of bundled payment reforms on racial and socioeconomic disparities in hip and knee surgeries.

Dr. Glance has over 20 years of experience working on surgical outcomes, quality measurement, and policy evaluations. He has published over 140 peer-reviewed papers, 83 of which as either first or last author. He serves on the National Quality Forum (NQF) Scientific Methods Panel, which evaluates the scientific validity of all complex quality measures submitted to NQF.

Competing Interests: Dr. Glance declares no competing interests. 

Dr. Todorovic is the inaugural CU Medicine Endowed Chair and Chair of the Department of Anesthesiology at the University of Colorado School of Medicine, Aurora, CO. She received her graduate education at the University of Belgrade in Serbia (M.D.) and the University of Illinois, Chicago (Ph.D.) and completed residency training in Anesthesia at the Washington University of School of Medicine in St. Louis, MO. She earned an M.B.A. from the University of Virginia, Charlottesville, VA, and received the Harold Carron Professor of Anesthesiology Endowment from the University of Virginia Health System during her time on the faculty there.

Dr. Todorovic is a practicing anesthesiologist and has been working simultaneously as a clinician scientist for over 25 years. She has developed three major lines of research: anesthetics as neurotoxins, the management of chronic pain and the mechanisms of anesthesia-induced developmental neurodegeneration. Dr. Todorovic’s research is federally funded and has resulted in over 140 peer-reviewed publications and 11 patents. Dr. Todorovic was the Chair of the National Institute of Health’s Surgery, Anesthesiology and Trauma study section. She also serves on the Editorial Board for the Journal of Neurosurgical Anesthesiology and the Associate Editorial Board for British Journal of Anaesthesia. Dr. Todorovic was a member of the Board of Directors for the International Society for Anaesthetic Pharmacology from 2007 and served as the Chairman in 2015.

In her role as a PI, Dr. Todorovic has mentored and trained over 60 graduate students, medical students, and post-docs. As Chair of the Department of Anesthesiology, her focus extends to the mentorship and growth of junior faculty, expanding clinical programs and increasing collaboration with the School of Medicine and surrounding community.

Competing Interests: Dr. Todorovic declares no competing interests.

Dr. Ji is the William Maixner Professor of Anesthesiology (2022), Distinguished Professor of Anesthesiology (2012), chief of pain research within Duke Anesthesiology, director of the Center for Translational Pain Medicine, and a professor of anesthesiology and neurobiology. His research focuses on chronic pain mechanisms and development of novel pain therapeutics. His group studies how neuroinflammation, glial cells, immune cells, cancer cells, and stem cells regulate pain. His group also investigates how inflammatory mediators and ion channels regulate neuronal excitability and synaptic transmission in chronic pain.

Dr. Ji is internationally recognized for demonstrating important roles of MAP kinase signaling pathways, glial cells, and neuroinflammation in the pathogenesis of chronic pain. His work has revealed many molecular targets for pain modulation, including specialized pro-resolution mediators (SPMs, e.g., resolvins and protectins), PD-L1/PD-1, MAP kinases, proteases (MMPs), secreted miRNAs, chemokines, TLRs, and Sting. Dr. Ji has published over 200 peer-reviewed papers, including many in top medical and neuroscience journals. Before moving to Duke University, he had been a faculty member of Harvard Medical School at Massachusetts General Hospital (1998-2003) and Brigham Women’s Hospital (2003-2012).

Competing Interests: Dr. Ji is an Editorial board member for Journal of Neuroscience, Pain, Neuroscience, and Neuroscience Bulletin, and consults for Boston Scientific.

Dr. Ladha is a staff Anesthesiologist at St. Michael’s Hospital and an Associate Professor in the Department of Anesthesiology and Pain Medicine at the University of Toronto, ON, Canada. He is a Clinician-Scientist at the Li Ka Shing Knowledge Institute and the co-director of the PINNACLE research group. Dr. Ladha received his medical degree from the Johns Hopkins University School of Medicine, Baltimore, MD, completed his anesthesia training at Massachusetts General Hospital, and obtained a fellowship in cardiac anesthesia at Toronto General Hospital. He also holds a master’s degree in clinical epidemiology from the Harvard School of Public Health, Boston, MA.

Dr. Ladha's program of research uses mixed methodologies to obtain a multifaceted view of pain and recovery after surgery including retrospective analyses of administrative databases, prospective observational studies, and multi-center randomized controlled trials.

Competing Interests: Dr. Ladha is a co-principal investigator of an observational study on medical cannabis funded by Shoppers Drug Mart.

Dr. Lane-Fall is Executive Director of the Penn Implementation Science Center at the Leonard Davis Institute of Health Economics (PISCE@LDI), Vice Chair of Inclusion, Diversity, and Equity and David E. Longnecker Associate Professor of Anesthesiology and Critical Care and Associate Professor of Biostatistics at the Perelman School of Medicine, University of Pennsylvania.

Dr. Lane-Fall’s research focuses on the uptake and use of evidence-based practices in acute care. Her work sits at the intersection of implementation science, human factors engineering, and improvement science. Current efforts are directed at facilitating the uptake of standardized perioperative handoffs and developing interventions to improve patient outcomes after critical illness. Dr. Lane-Fall is also interested in the use of qualitative and mixed methods in perioperative research.

Competing Interests: Dr. Lane-Fall is the Vice President of the Anesthesia Patient Safety Foundation, is on the Board of Directors for the Foundation for Anesthesia Education and Research, and her institution receives grant funding for her research and training efforts from the U.S. National Institutes of Health, the Agency for Healthcare Research and Quality, the Patient Centered Outcomes Research Institute, and the American Heart Association.

Dr. Lerner's research interests have centered around the clinical care of patients undergoing cardiac surgical procedures and liver transplantation. His primary area of focus surrounds coagulation and anticoagulation and includes the management of heparin and protamine dosing in cardiac surgery, the use of antifibrinolytics in both cardiac surgical and liver transplantation patients, the role of thromboelastography based transfusion protocols in reducing transfusion, and potential hypercoagulability in end-stage liver failure patients. His secondary interests are targeted around transesophageal echocardiography (TEE) and include TEE indices of diastolic dysfunction, establishing the validity of intraoperative 3-dimensional TEE, and the use of intracardiac and intravascular ultrasound in cardiovascular surgery. He currently practice anesthesiology in Charleston, South Carolina.

Competing Interests: Dr. Lerner has no competing interests to report.

Professor Leslie is Head of Research in the Department of Anaesthesia and Pain Management at the Royal Melbourne Hospital. She is an Honorary Professorial Fellow in the Anaesthesia Perioperative and Pain Medicine Unit, Melbourne Medical School, and Department of Pharmacology and Therapeutics, University of Melbourne, and Honorary Adjunct Professor, Department of Epidemiology and Preventive Medicine, Monash University.

Professor Leslie's research interests include awareness and depth of anaesthesia, large clinical trials in anaesthesia and perioperative medicine, and sex/gender equity in research. She is a member and former chair of the Australian and New Zealand College of Anaesthetists Clinical Trials Network. Prof. Leslie's clinical interests include neurosurgery, general surgery and trauma surgery.

Competing Interests: Dr. Leslie declares no competing interests.

Dr. Lirk is Attending Anesthesiologist in the Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women’s Hospital and Associate Professor at Harvard Medical School, Boston, MA.

Dr. Lirk’s research interests revolve around the pharmacology and toxicology of local anesthetics, and their clinical applications in regional anesthesia and acute pain management. His clinical work is centered around Trauma, Orthopedic and Regional Anesthesia. Motivated by the Covid-19 pandemic, he is currently working on his M.P.H. degree with a concentration in Emergency Preparedness at the University of Nebraska Medical Center (UNMC), Omaha, NE, with an elective in Biohazardous Threat Agents and Emerging Infectious Diseases at Georgetown University, Washington, DC.

Competing Interests: Dr. Lirk declares no competing interests.

Dr. Mashour is the Robert B. Sweet Professor and Chair of Anesthesiology; Director, Michigan Psychedelic Center; Professor of Neurosurgery and Pharmacology; and Faculty, Neuroscience Graduate Program, at the University of Michigan Medical School, Ann Arbor, Michigan.

Dr. Mashour is an anesthesiologist and neuroscientist whose primary scholarly interest relates to consciousness and anesthetic-induced unconsciousness. His clinical research focuses on neurologic and psychiatric outcomes of surgery. Dr. Mashour's laboratory investigates mechanisms of unconsciousness during sleep and anesthesia. His theoretical research group explores network science approaches to understanding consciousness and anesthetic-induced unconsciousness. In addition to numerous peer-reviewed publications, Dr. Mashour has edited five textbooks related to anesthesiology and the neurosciences.

Funding: National Institutes of Health

Competing Interests: Dr. Mashour declares no competing interests.

Dr. Mazzeffi is Professor of Anesthesiology and Vice Chair for Faculty Affairs and Development, University of Virginia School of Medicine, Charlottesville, VA.

Dr. Mazzeffi’s research interests include extracorporeal membrane oxygenation, coagulation and hemostasis, mechanical circulatory support, cardiovascular critical care outcomes, patient blood management, obstetric critical care, and health disparities. His research has been funded by the Society of Cardiovascular Anesthesiologists and Anesthesia Patient Safety Foundation. A current area of research focus is treatment of ECMO-induced coagulopathy with recombinant von Willebrand Factor and other novel therapies.

Competing Interests: Dr. Mazzeffi reports past receipt of consulting fees from Hemosonics and Octapharma and receipt of research support from Cellphire Corporation.

Dr. McIsaac is an Associate Professor of Anesthesiology & Pain Medicine, and Epidemiology & Public Health at the University of Ottawa, where he holds a Clinical Research Chair in Innovative Perioperative Care.

Dr. McIsaac’s perioperative research program uses observational methods in large data sets, knowledge synthesis and clinical trials to identify, evaluate and implement processes and interventions to improve outcomes for high-risk surgical patients. He has specific interest and expertise in the care of older people and those with frailty. Dr. McIsaac also serves on the Editorial Board of the Canadian Journal of Anesthesia.

Competing Interests: Dr. McIsaac declares no competing interests.

Dr. Moon is an Assistant Clinical Professor in the Department of Anesthesiology & Perioperative Medicine at the University of California, Los Angeles.  She graduated magna cum laude from Harvard University with a degree in History and Literature and worked as a high school history teacher before starting medical school. She completed her M.D. and her anesthesiology residency and critical care fellowship at the University of Southern California.

Dr. Moon has had a longstanding interest in the history of ideas and began to develop a keen interest in the history of anesthesia during her residency years. She enjoys bringing history to life and appreciates its value in informing and inspiring the present (and future). As an author of the monthly historical "Reflections from the Wood Library-Museum" and as an editor of the "Classic Papers Revisited" section in Anesthesiology, Dr. Moon hopes to invoke a sense of wonder by highlighting developments that have shaped or been shaped by anesthetic practice.

Competing Interests: Dr. Moon declares no competing interests.

Dr. Muehlschlegel is Director of the Department of Anesthesiology and Critical Care Medicine at Johns Hopkins University School of Medicine, Baltimore, MD.

Dr. Muehlschlegel’s research interests center on the impact of genetic variation upon adverse cardiovascular events, and their significance on a functional level. He is the principal investigator of the TRANSCRIBE study, examining the genetics of gene expression in human myocardium at baseline and after exposure to ischemia by performing an eQTL analysis, and the RECHARGE study, in which he aims to identify variants associated with Rheumatic Heart Disease in a Rwandan cohort of cardiac surgical patients.

Dr. Muehlschlegel’s clinical interests are cardiac anesthesiology with significant subspecialty training in all aspects of cardiac disease and transesophageal echocardiography. His particular expertise is in the area of myocardial injury and its association with cardiac specific biomarker elevation, as well as in defining the role that the ECG has in the acute myocardial injury setting immediately post cardiac surgery.

Funding: National Institute of Health (US), National Institute of Health Research (UK).

Competing Interests: Dr. Muehlschlegel declares no competing interests.

Professor Myles is the Chair of the Department of Anaesthesiology and Perioperative Medicine, as well as the current Director of Anaesthesiology and Perioperative Medicine at the Alfred. In addition, Professor Myles is an Australian NHMRC Leadership Fellow (L3), and Fellow of the Australian Academy of Health and Medical Sciences.

Professor Myles has published more than 350 papers and is an editor of the British Journal of Anaesthesia.

Funding: Professor Myles is part-funded by an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship.

Competing Interests: Professor Myles declares no competing interests.

Dr. Neuman is Horatio C. Wood Associate Professor of Anesthesiology and Critical Care and Associate Professor of Medicine (Geriatrics) at the University of Pennsylvania, Philadelphia, PA. In addition, he is Co-Director of the Penn Center for Perioperative Outcomes Research and Transformation (CPORT) and a Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania.

Dr. Neuman's clinical areas include adult general anesthesia, anesthesia for older adults, and anesthesia for orthopedic surgery. His current research interests focus on comparing the effectiveness of different anesthesia techniques for improving patient-centered outcomes after hip fracture surgery. Prior studies have employed large retrospective databases to address questions of comparative effectiveness in the perioperative setting, and to examine the health-system factors associated with adverse outcomes among older adults undergoing major surgical procedures.

Competing Interests: Dr. Neuman declares no competing interests.

Dr. Palmer is Professor Emeritus of Anesthesiology in the College of Medicine, University of Arizona, Tucson, AZ. He is lead author of Obstetric Anesthesia (2011), and the Handbook of Obstetric Anesthesia (2000).

Dr. Palmer's research interests include obstetric anesthesia, particularly regional anesthesia for labor and delivery, anesthesia for cesarean delivery, and intrathecal opioids for labor and post-partum/post-operative analgesia. He maintains an on-going interest and activity in improving and developing obstetric anesthesia practice internationally.

Competing Interests: Dr. Palmer declares no competing interests.

Dr. Proekt is an Associate Professor in the Department of Anesthesiology and Critical Care at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. He received his B.S. in biological sciences from Carnegie Mellon University, Pittsburgh, PA, and his dual M.D. and Ph.D. in neuroscience from the Mount Sinai School of Medicine, New York, NY. In 2021, he was the recipient of ASA’s James E. Cottrell, M.D., Presidential Scholar Award.

Dr. Proekt’s interests include neuroscience, mechanisms of general anesthesia, and mathematical modeling.

Competing Interests: Dr. Proekt declares no competing interests.

Dr. Rivat is an Associate Professor at University of Montpellier and at the Institution of Neuroscience in Montpellier (INM) INSERM U1298, Montpellier, France.

Dr. Rivat’s research interests focus on the identification of the molecular mechanisms at the central and peripheral nervous system that underlie the transition from acute to chronic pain. This involves long-term plasticity induced by incisional surgery, peripheral nerve lesion, large doses of opioids, and stress. Current efforts are directed at the study of the neuroimmune communication in the maintenance of peripheral neuropathic pain. Dr Rivat is also interested in developing pharmacological multimodal interventions to limit pain chronification.

Competing Interests: Dr. Rivat declares no competing interests. 

Dr. Sall is Professor of Anesthesia at the University of California, San Francisco, CA. He obtained his undergraduate degree from the University of Nebraska, Lincoln, NE. His M.D. and Ph.D. were received from the University of Iowa, Iowa City, IA, where he also completed an internship in internal medicine. Dr. Sall undertook his anesthesia residency and a research fellowship at the University of California, San Francisco.

Dr. Sall’s clinical work is primarily focused on obstetric and neurosurgical services. His laboratory research efforts have focused on how anesthetics interact with the developing brain. In addition, he works with the hypoxia research group studying the effects of hypoxia and rapid ascent to altitude.

Competing Interests: Dr. Sall is on the scientific advisory board for Smart Tots. He has received research funding from NIH, FAER, Smart Tots, and Tasly Pharmaceuticals.

Dr. Sandberg is Chair of the Department of Anesthesiology at Vanderbilt University School of Medicine and Professor of Anesthesiology, Surgery, and Biomedical Informatics. He also serves as Chief of Staff for the Vanderbilt University Adult Hospital. Dr. Sandberg has led the Department of Anesthesiology at Vanderbilt since 2010 and added Chief of Staff responsibilities in 2018.

Dr. Sandberg received his Ph.D. in biochemistry and molecular biology from the University of Chicago, and his M.D. from the University of Chicago, Pritzker School of Medicine. He served his internship at the University of Chicago Hospitals and was a resident/fellow in the Department of Anesthesia/Critical Care at Massachusetts General Hospital. Dr. Sandberg joined the Harvard faculty in 1998 where he served until his selection as chair at Vanderbilt, April 2010.

At Vanderbilt, Dr. Sandberg divides his time between clinical practice, research, and administration. Vanderbilt is a recognized national leader in informatics, quality and health outcomes research, which aligns with his clinical and research interest in the development and use of informatics in anesthesiology. Dr. Sandberg’s specific research interests include factors affecting physician-patient communication, perioperative systems design, and OR workflow management. In his role as Chair of the Department of Anesthesiology, his goal is to leverage forward thinking technologists and the already present capabilities of the institution to develop a world class anesthesia informatics and real-time decision support research program.

Competing Interests: Dr. Sandberg declares no competing interests.

Dr. Schwartz is Professor of Anesthesiology & Critical Care at the University of Pennsylvania School of Medicine, Philadelphia, PA.

Dr. Schwartz’s interests include clinical care and education with special emphasis on pediatric and cardiothoracic anesthesiology and cardiopulmonary resuscitation.

Competing Interests: Dr. Schwartz declares no competing interests.

Dr. Sessler attended medical school at Columbia University, and subsequently completed pediatric and anesthesia residencies at the University of California, Los Angeles. After stints as professor at UCSF and vice dean at the University of Louisville, his current position is Michael Cudahy Professor and Chair of the Department of Outcomes Research at the Cleveland Clinic. Dr. Sessler published a book on therapeutic hypothermia and more than 875 full research papers, including two-dozen in the New England Journal of Medicine and Lancet. More than 120 of his papers were accompanied by editorials, and more than two-dozen were cover articles for major anesthesia journals since 2010. Dr. Sessler’s papers have been cited more than 55,000 times in peer-reviewed articles — making him the world’s most published and cited anesthesiologist. He is among the top 0.02% of cited scientists in any field, with an H Index of 112.

Dr. Sessler has been a principal or co-investigator on grants totaling more than $80 million. He founded and directs the Outcomes Research Consortium. The Consortium is the world’s largest clinical anesthesia research group, and publishes a full paper every 2.5 days. He was an editor of Anesthesiology for 9 years, and serves as a director for the Foundation for Anesthesia Education and Research (FAER). He has given invited lectures at more than 400 institutions. Dr. Sessler’s awards include a Fulbright Fellowship and the American Society of Anesthesiologists Excellence in Research prize.

Competing Interests: Dr. Sessler has disclosed the following: Advisory Boards (3M, 37 Company), consultant (B. Braun, Edwards, Medtronic, Pacira), stock options (E-Motion, Medasense, Calorint, VitaHEAT), Board of Directors (FAER), and Funded Research (Dept of Defense, NIH, Canadian Institutes of Health Research, Fresenius, Merck, Advanced Cooling, 3M, La Jolla, Sotera Wireless). All temperature-related fees are donated to charity.

Dr. Simpao is an Associate Professor of Anesthesiology and Critical Care at the Children's Hospital of Philadelphia (CHOP) and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

Dr. Simpao is a board-certified pediatric and maternal-fetal anesthesiologist and clinical informatician. He is the Associate Chief for Research in the Division of General Anesthesiology, Director of the Biomedical Informatics Program in the Department of Anesthesiology and Critical Care Medicine, and an Associate Director of Anesthesia Services at CHOP's King of Prussia Hospital. Dr. Simpao is the Deputy Editor of Journal of Medical Systems and President-Elect of the Society for Technology in Anesthesia. His research focuses on using informatics and analytics for research and quality improvement. He has lectured internationally on informatics, analytics, and artificial intelligence in pediatric perioperative care, maternal-fetal anesthesia, and physicians' use of social media for networking, education, and advocacy.

Competing Interests: Dr. Simpao assumed the position of the Deputy Editor of Journal of Medical Systems published by Springer Nature in March 2023. He is the PI for CHOP on a multisite study for Eagle Pharmaceuticals, Inc.; however, the study has not been launched yet, and he has not received any compensation for this role.

Dr. Skubas is Chair of the Department of Cardiothoracic Anesthesiology in the Anesthesiology Institute of Cleveland Clinic, Cleveland, OH. Dr. Skubas earned his medical degree from Aristoteles University in Thessaloniki, Greece. He completed his internship and anesthesiology residency at University Hospitals Case Medical Center, Cleveland, OH and a two-year fellowship in Cardiothoracic Anesthesiology at Washington University in St. Louis, Barnes-Jewish Hospital, St. Louis, MO. Dr. Skubas is a fellow of the American Society of Echocardiography (FASE) and American College of Cardiology (FACC).

Dr. Skubas has published extensively in peer-reviewed journals, and co-authored practice guidelines sponsored by the American Society of Echocardiography, American College of Cardiology and American Heart Association. He is a co-editor of the Problem-Oriented Patient Management, 8th edition, and of the Savage & Aronson’s Comprehensive Textbook of Perioperative and Critical Care Echocardiography, 3rd edition He has served on the editorial board of the journal Anesthesia and Analgesia since 2005 and he is the Executive Section Editor for Perioperative Echocardiography and Cardiovascular Education.

Dr. Skubas is Chair of the Basic Perioperative Transesophageal Echocardiography (Basic PTeXAM) Writing Committee and member of the Board of Directors of the National Board of Echocardiography.

Competing Interests: Dr. Skubas declares no competing interests.

Dr. Solt is Associate Professor in the Department of Anesthesia, Critical Care and Pain Medicine at Massachusetts General Hospital and Harvard Medical School, Boston, MA.

Dr. Solt’s research focuses on neural circuit mechanisms of general anesthesia and anesthetic emergence. In the laboratory, he utilizes a systems neuroscience approach to elucidate these mechanisms in animal models, while his clinical research interest is in developing methods to improve recovery from general anesthesia in surgical patients.

Competing Interests: Dr. Solt declares no competing interests.

Dr. Story is Professor of Anaesthesia and Head of the Department of Critical Care at the University of Melbourne. He is a member of Council of the Australian and New Zealand College of Anaesthetists (ANZCA), and ANZCA Vice President.

Dr. Story's main research interest is clinically and cost-effective approaches to reduce perioperative risk, complications, disability, and mortality. He also does translational work in acid-base disorders and is a consumer investigator in diabetes care. Dr. Story is a Staff Anaesthetist at the Austin Hospital where he provides perioperative care for most procedural specialties, including liver transplantation.

Competing Interests: Dr. Story has previously been on an advisory board for Grey Innovation and received research funding from the Medibank Better Health Foundation.

Dr. Struys is Professor and Chair of the Department of Anesthesiology at the University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. He is also affiliated as Professor to the department of Anesthesiology, Ghent University, Gent, Belgium. He is a board-certified anesthesiologist in Belgium and the Netherlands and is also board certified as a clinical pharmacologist in the Netherlands.

Dr. Struys' main research interest is in clinical pharmacokinetics and pharmacodynamics and drug administration technology, including intravenous and inhaled anesthetics, target controlled infusion techniques, closed-loop systems and drug interaction behavior. Additionally, he is working on the validation of various types of anesthesia monitoring and equipment for measuring drug effects. His main clinical interest is in anesthesia for oncological and abdominal surgery.

Competing Interests: Over the past 3 years, Dr. Struys' research group/department received research grants and consultancy fees from The Medicines Company (Parsippany, NJ, USA), Masimo (Irvine, CA, USA), Becton Dickinson (Eysins, Switzerland), Fresenius (Bad Homburg, Germany), Dräger (Lübeck, Germany), Paion (Aachen, Germany), Medtronic (Dublin, Ireland), and Medcaptain Europe (Andelst, The Netherlands). He receives royalties on intellectual property from Demed Medical (Temse, Belgium) and the Ghent University (Gent, Belgium).

Dr. Sun is a graduate of the University of Chicago, where he received his medical degree and a Ph.D. in business economics. After completing a residency in anesthesiology at Stanford University, he stayed on as a faculty member, where is now an Assistant Professor in the Department of Anesthesiology, Perioperative and Pain Medicine and (by courtesy) the Department of Health Research and Policy.

Dr. Sun's research primarily examines the effectiveness of clinical therapies and healthcare policies in reducing opioid use among preoperative patients and among patients with chronic pain.  In addition, he also studies the economics of physician behaviors.  These research efforts are supported by the National Institute on Drug Abuse and the National Institute on Aging.

Competing Interests: Dr. Sun is an advisor for Lucid Lane, LLC and has received consulting fees from Analysis Group, Inc.  In addition, he has received research funding from the American Society of Anesthesiologists, the National Institute on Drug Abuse, and the National Institute on Aging.

Dr. Sweitzer is Systems Director, Preoperative Medicine, Inova Health, Falls Church, Virginia, and Professor of Medical Education, University of Virginia.

Dr. Sweitzer is an author and the editor of Preoperative Assessment and Management (currently 3rd edition). She has authored over 100 peer-reviewed manuscripts and abstracts and over 30 book chapters. She lectures nationally and internationally on preoperative medicine and ambulatory surgery topics. She is the Executive Editor of A&A Practice, and on the editorial board of Anesthesiology and Anesthesia and Analgesia. She hosts a monthly podcast for Anesthesiology.

Dr. Sweitzer is a past President of the Society of Ambulatory Anesthesia (SAMBA). She is a Fellow of the American College of Physicians, the American Society of Anesthesiologists and SAMBA. She is an elected member of the Association of University Anesthesiologists, and a founding member of the Governing Board and past President of the Society of Perioperative Assessment and Quality Improvement. She is a founding member of the Society for Anesthesia and Sleep Medicine.

Competing Interests: Dr. Sweitzer receives funding from IARS and UpToDate.

Dr. Wanderer is a Professor of Anesthesiology and Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN. At Vanderbilt, he is the Associate Fellowship Director for the Clinical Informatics Fellowship Program and co-course director for the Foundations of Clinical Informatics in the Masters of Applied Clinical Informatics Program. He leads Vanderbilt's Physician Builder program and is Medical Director of Perioperative Informatics.

Dr. Wanderer’s research is focused on applying clinical informatics to improve the delivery of healthcare in the perioperative and acute care settings, leveraging clinical decision support, data science and novel technology-based solutions.

Competing Interests: Dr. Wanderer has received funding from NIH, NSF, FAER and IBM.

Dr. Wijeysundera is a Staff Anesthesiologist at St. Michael’s Hospital, and a Professor in the Department of Anesthesiology and Pain Medicine at the University of Toronto, ON, Canada. In addition, he is a Professor of Health Policy, Management and Evaluation at the University of Toronto, a Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, and a Senior Adjunct Scientist at ICES (formerly called the Institute for Clinical Evaluative Sciences) in Toronto, Ontario. Dr. Wijeysundera holds the Endowed Chair in Translational Anesthesiology Research at St. Michael’s Hospital and University of Toronto.

Dr. Wijeysundera's research program, which aims to help prevent complications following major surgery, has generated more than 300 peer-reviewed publications, and received peer-reviewed funding from the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, PSI Foundation, and the Ontario government. Dr. Wijeysundera is an editorial board member at the Canadian Journal of Anesthesia, Anesthesiology, and Circulation, as well as a past member of the American College of Cardiology (ACC) and American Heart Association (AHA) Task Force on Practice Guidelines.

Competing Interests: Dr. Wijeysundera has received honoraria from Edwards Lifesciences, and is a member of the Scientific Advisory Board of Surgical Safety Technologies Inc.

Dr. Wunsch is an intensivist in the Department of Critical Care Medicine at Sunnybrook Hospital and Professor in the Department of Anesthesiology and Pain Medicine and the Interdepartmental Division of Critical Care Medicine at the University of Toronto, ON, Canada. She is also the Associate Director of Critical Care Research at the University of Toronto and holds a Canada Research Chair [Tier 2] in Critical Care Organization and Outcomes.

Dr Wunsch’s research focuses on the organization, and delivery of critical care services, with a particular focus on international comparisons of critical care, use of large databases to understand resource utilization, and pharmaco-epidemiology.

Competing Interests: Dr. Wunsch declares no competing interests. 

Michael Zaugg is a Full Professor in the Department of Anesthesiology and Pain Medicine at the University of Alberta, Edmonton (Canada), Senior Staff Anesthesiologist at the University of Alberta Hospital, Edmonton, Adjunct Professor of Pharmacology, Department of Pharmacology, University of Alberta, and Executive Member of the Cardiovascular Research Centre, Faculty of Medicine and Dentistry, University of Alberta.

Dr. Zaugg is a clinician-scientist with a translational research program focused on the pharmacology of drugs used in anesthesia and intensive care medicine. His program is funded by the Canadian Institutes of Health Research, the Heart & Stroke Foundation of Canada, and the Swiss National Science Foundation. In 2005, he was recipient of the IARS Frontiers in Anesthesia Research Award, a renowned international research price granted by the International Anesthesia Research Society.

Competing Interests: Dr. Zaugg declares no competing interests.